ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000702.1|Kanamycin_1 # 3 # 533 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.663	BGC0000702.1|Kanamycin_1	3	533	+	Perfect	275	358.992	AAC(6')-Ib-SK	100.0	3002593	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCGGGCACATCGGAGCTGCTGCATCCGCAGGCGCGGGCTCGGGCACAATGCAGGAGTGGAACTGAACGGTGAGAAAGTGCTGCTGCGGCCCGTGCTCGACAGCGATGTGAAGAAGCTCGACAAGATCGTCAGAGAACCCGAGGTGGCCGCTTGGTGGTCGACCCCCGATGACTACGAGGAGATGCTCGCCATCACCCTCGACGGCGAGGTCATCGGGGCAGTGCAGTACGAGGAGGAGGAAGACCCCGAGTTCCGCCACGCGGGCATCGACATCTTCCTCACGGCGAGTCGGCACGGCCTCGGCCTCGGCACGGACACCGTCCGCACCGTGGCACGTTGGCTGATCGACGAGCGGGGACACCACCGGATCACCATCGACCCGGCGGTGGCGAACGCGGGCGCGATCCGCAGCTACAGCAAGGTGGGCTTCAAGCCGGTCGGCGTCATGCGGTCATACGCCCGTGACCACACGAGCGGCGTGTGGCAGGACGCCCTGCTGATGGACCTGCTGGCCGAAGAGCTGGTCTGA	MRAHRSCCIRRRGLGHNAGVELNGEKVLLRPVLDSDVKKLDKIVREPEVAAWWSTPDDYEEMLAITLDGEVIGAVQYEEEEDPEFRHAGIDIFLTASRHGLGLGTDTVRTVARWLIDERGHHRITIDPAVANAGAIRSYSKVGFKPVGVMRSYARDHTSGVWQDALLMDLLAEELV	MRAHRSCCIRRRGLGHNAGVELNGEKVLLRPVLDSDVKKLDKIVREPEVAAWWSTPDDYEEMLAITLDGEVIGAVQYEEEEDPEFRHAGIDIFLTASRHGLGLGTDTVRTVARWLIDERGHHRITIDPAVANAGAIRSYSKVGFKPVGVMRSYARDHTSGVWQDALLMDLLAEELV	100.00	gnl|BL_ORD_ID|967|hsp_num:0	1024		
BGC0000702.1|Kanamycin_2 # 599 # 1777 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.715	BGC0000702.1|Kanamycin_2 	599	1777	-	Loose	500	26.5646	chrB	31.67	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGGGGGCTGACTTGGCCCATACGGCGACCGTGGCCCAGTACGTCAGTGCCGCCGCCATGGGGGCGGTGGTCCTGTTGCGCGCCCCCGCCGCCGCCCGGAGTCCGGCCCAGCGCGGCCTGTGGCTGGCCGTCGCGACGGCCGCGGTCGCCATGGCGCTGCAACTGCCGGTCGTCATCAGGGCCGCCCTCGACCTCACGGGCAGCGTGCACGAGGTGGGTCTGGCCAGGAACCTCTTCGGGGTGTTGTCGGCGGGGTGCGTGCTGTACTTCGTCACGGCGGCGGCCCAGCACCGCTGGTGGCGCTGGGGACTCGTCACGTCGGTGGCGCTGGTCGTCCTCGCCCTGGTCCTGCTCGACCAGGTGCGGGAACAGCACGACAACCCGGGCGGTCCTTCGTCGCTCAGCGCGTACTGGGCCATCCTGATGGGCAGTCACATCGTGGCCAACACGGTCTGCGTCCACGTGTGTCTGTGGCAGGGCTGCCGGGCCTCGGCCCCTTCTCTCCGCCTCAGCCTGTGGATCTTCGGGGCGGGCACGGCTCTGGTCGGGATCTATTGGTGCGTGGCCCTTGGACGGCTGATCATCGGTGAGCCGCCCCTGCGGAACCTGTCCCTGCTGATGAGCCTGCACGGCTTCCTGCGGGCGGCCGCCCTGCTGGTGCCCCTGTGGGGCTCGATGCGCTCCCAGCCGTCACAGATCAGGACCCTGTGGGTGCTGTGGCCCCTGTGGCGAACCCTGGTGCAGGCGGTGCCGCACGTGGCGCTCCACCGGCGGCGCTCCCGGATCGTCGAGGTGGTGTGGCCGCGCGCGCCGCGCCGACTGGCCGTCTACCGCAGGATGATCGAGATACGGGACGCGATCCTCTCCCTGCACGGCTACGTCCATCCCGCGCTGCCGGGAGCCGTGAAGAGCCGGGTGGAACAGCTGGGTCTGCACGGGCGCTCCGCCGACGCGATGACGCTGGCCTGTCTCCTGCACGTGGCCCTGCGGGCCAGGCGGACGGGGGCGGCCAAGGACTTCGACGCCTCCCTCTCCCACGGCTGGGACAGCGTGAACATCTCTGGTGAAGAATCGTTTCTTCTGGAACTCGCACGCGCCTTCCGCACGCCGGTCGCCCGCTCGCTCGCCGGTCAGCTCGGCGGCCGGACGGGCGGCCTCACCGAGGTCGGCGACGGGTGA	MGADLAHTATVAQYVSAAAMGAVVLLRAPAAARSPAQRGLWLAVATAAVAMALQLPVVIRAALDLTGSVHEVGLARNLFGVLSAGCVLYFVTAAAQHRWWRWGLVTSVALVVLALVLLDQVREQHDNPGGPSSLSAYWAILMGSHIVANTVCVHVCLWQGCRASAPSLRLSLWIFGAGTALVGIYWCVALGRLIIGEPPLRNLSLLMSLHGFLRAAALLVPLWGSMRSQPSQIRTLWVLWPLWRTLVQAVPHVALHRRRSRIVEVVWPRAPRRLAVYRRMIEIRDAILSLHGYVHPALPGAVKSRVEQLGLHGRSADAMTLACLLHVALRARRTGAAKDFDASLSHGWDSVNISGEESFLLELARAFRTPVARSLAGQLGGRTGGLTEVGDG	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	140.00	gnl|BL_ORD_ID|284|hsp_num:0	305		
BGC0000702.1|Kanamycin_3 # 1767 # 2354 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.662	BGC0000702.1|Kanamycin_3 	1767	2354	-	Loose	225	24.2534	FosB	38.1	3000172	protein homolog model	n/a	n/a	fosfomycin	antibiotic inactivation	fosfomycin thiol transferase	ATGCATGTCCGCAGGACCGCCTACTACCGATGCCCCGCTCAAGGCCTACGGAAAGAGCATATGTCTTATATATATGTGAAACTCCGACAGCGTTGCCAGGCGATCGTGGACGGACTCAGCCTGCCGCACCCCTTCACCGTCGAATCCTTCTGTACGCGCCTCGCGGCCCAGCGTCAGCGGCCCCTTCATCTGCACGCCTTGCCGCGGCAGGCGGCCCAGGCGGGCGCGTGCGGATTGTGGCTGGCCACGGACATCGACGACCACATCTTCTTCGAGCAGCGCACGGCCCGCGTGCATCAGGACCACATCATCCTGCACGAGATCGGCCACATGCTCTTCGGTCATCAATCGCTCGAACTGGGCGAGGGCTGGGGCGATGCGCCCCAGCTCTTCGGGGACCTCAGCCCGCAGCTGATCCAACGGCTGCTCGCCCGCACCGACTACACCACCCGGCGGGAGCAGGAGGCCGAGATGCTGGCCAGCCTGATCCGCACCAGGGGCGAACAGCCCGCCGGTGAACGGCACGCGGACGACGTGCTTCACTACCTCGGCGAGGCACTCGGCGTGGGAGCGACCCGTGGGGGCTGA	MHVRRTAYYRCPAQGLRKEHMSYIYVKLRQRCQAIVDGLSLPHPFTVESFCTRLAAQRQRPLHLHALPRQAAQAGACGLWLATDIDDHIFFEQRTARVHQDHIILHEIGHMLFGHQSLELGEGWGDAPQLFGDLSPQLIQRLLARTDYTTRREQEAEMLASLIRTRGEQPAGERHADDVLHYLGEALGVGATRGG	MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEVHQSYTHIAFSVEQEDFKCLIQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRDEKPHMTFY	141.30	gnl|BL_ORD_ID|1474|hsp_num:0	1567		
BGC0000702.1|Kanamycin_4 # 2412 # 2894 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.615	BGC0000702.1|Kanamycin_4 	2412	2894	-	Loose	700	24.2534	mdtG	35.71	3001329	protein homolog model	n/a	n/a	fosfomycin	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGGGACGGCGCGGCGGAGCGTTCCGAAAGCGGCAGGCTGCTGCTGGATAAACTCGACCAGCGCATCAAAGATCTCATTTGCGCCATCTATCCGGACAAGGGCACCCGGCCCGGTTATGCGCGGCTCGCGCAGGACATAAGAGAAACCACCGGCGGGACCATCTCGGGAACGTACCTATGGGAATTGGCCACCGGCAAGAAACGAAACGTCACGCTGGAACAACTCGGTGTCCTGGCAGACTATTTCGGGGTACCGCCTGAGTACTTCCTCAATGACGAGGTGTCCGAACGGGTAAACGCTCAACTCGCACTGGCAACGGCCCTCAGGGACAACCGGATTCGCAATCTCGCGCTTCGGGCGGAAGGCCTTTCGCCCTCCACCTTGGACGCGTTGCTGGTCATGGTGAACGAGGCCCGGAAGATCCAGAACCTGTCCCCACCGGCTGACGAAGACGGGCGCGGTCCCCAGCACACGGAGTGA	MRDGAAERSESGRLLLDKLDQRIKDLICAIYPDKGTRPGYARLAQDIRETTGGTISGTYLWELATGKKRNVTLEQLGVLADYFGVPPEYFLNDEVSERVNAQLALATALRDNRIRNLALRAEGLSPSTLDALLVMVNEARKIQNLSPPADEDGRGPQHTE	MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVFSITFLFSAIASPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN	39.22	gnl|BL_ORD_ID|564|hsp_num:0	603		
BGC0000702.1|Kanamycin_5 # 3394 # 4431 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.751	BGC0000702.1|Kanamycin_5 	3394	4431	+	Loose	500	26.5646	sul4	40.91	3004361	protein homolog model	n/a	n/a	sulfonamide antibiotic	antibiotic target replacement	sulfonamide resistant sul	GTGCGCGAGAGTGATATCCAGGCCGCCTCGCTTCCCCCGGAAAGCAAGTCCGAGCTATTCCAGCGGAGTTCGGTGCGCGTTCCGCTCGACCTGCTCCTGCCCGCGGTGTCCCCCCGCATCGCAGGCGTGGACGAACGGCACGTCCGGTCGCTCGCCGGGATCGAGGCCCCGCTGCCGCCCATCGTGGTGCACCGCGCCACGCTGCGGGTGATCGACGGGACGCACCGGCTGCTCGCCGCCCGCGCCCGGGGGGAGACGGACGTGGAGGTGCAGTTCTTCGACGGCGGTGAGGCCGATGCCTTCGTCCTCGCCGTCGCCCTCAACAACGCCCAGGGGCTGGCGCTCTCCCCGGCCGATCGCAGTACGGCGGCGGCGCGCATCATCGCCTCCCATCCGCACTGGTCGGACCGCCGCATCGCCCGCGTCACCGGCCTGGCCGCCAGCACAGTGGGCGGTGTCCGCAGGCGTTCGACCGCTCGAACCGCACAGCCGAACGCGCGCCTCGGCATGGACGGCCGCATCCGCCCGCAGGACATCGCCCAACGGCGCAGGCTGGCCGGGCAGTTCCTCGCCGAGCAGCCGGGGGCCTCCCTGCGGACCGTGGCGAAGGCCGCCGGGATCTCCTTGAGCACGGCCCACGACGTACGGACGCGACTGCGGGCGGGCGACGATCCGCTGCCCCCCGCGCTGTCCAGGCCGACGCGGCCGCCCGCCGCGCCGGACAGCGCGGCCGACGCCGCGGACCGGCCCGCCAAGCCGTCCTCCGCACGCTCCCCGCGAAGCCCCGGGCGCGCCCCCGTCGCCGCCGATCTCCTGGACCGGCTGCGCAAGGACCCCTCGCTGAGGTTCACGGAGGACGGCCGGATCCTTCTTCACTGGCTCGGCGCCGCCGTGCTCCGCGAACACGGCGCCGCACGGTTCGCCCGCTGCGTACCGCCGCACAGGACCGCCGCCATGGCGGCCCTCGCCCGCAGCTGTGCGGAGGGCTGGCTCCGTCTCGCCGAATCCCTCGACCAGCGCGGCAGGTCCGACGCGTGA	MRESDIQAASLPPESKSELFQRSSVRVPLDLLLPAVSPRIAGVDERHVRSLAGIEAPLPPIVVHRATLRVIDGTHRLLAARARGETDVEVQFFDGGEADAFVLAVALNNAQGLALSPADRSTAAARIIASHPHWSDRRIARVTGLAASTVGGVRRRSTARTAQPNARLGMDGRIRPQDIAQRRRLAGQFLAEQPGASLRTVAKAAGISLSTAHDVRTRLRAGDDPLPPALSRPTRPPAAPDSAADAADRPAKPSSARSPRSPGRAPVAADLLDRLRKDPSLRFTEDGRILLHWLGAAVLREHGAARFARCVPPHRTAAMAALARSCAEGWLRLAESLDQRGRSDA	MSTTLTSFKWGERTYIMGILNVTPDSFSGDGVMVEEDVIAKAVAQAKQFVADGADIIDIGGESTRPGSSPISAEEELARVLPVVQAVRQAVDVVISIDSYRASVAEAALAAGASWLNDVWGLRMDPDMAGLAAQAGCPIVLMHNRSKPKNIAQEKKLGGRFIGVKYDDLITDVKRELQESIDIALKAGVKESQIILDPGIGFGKTVEQSLQLLDQINQFKTMGFPILIGPSRKSFIGYTLDLPPDQRIEGTAATVAIGIDRGADVVRVHDVKAIVRVARMTDAIVRR	120.21	gnl|BL_ORD_ID|2548|hsp_num:0	2875		
BGC0000702.1|Kanamycin_6 # 4526 # 5557 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.712	BGC0000702.1|Kanamycin_6 	4526	5557	+	Loose	600	29.6462	vanHM	24.18	3002947	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	GTGAAGGCACTCGTGTTCCACAGCCCCGAGAAGGCGACCTTCGAACAGCGCGACGTCCCCACTCCCCGGCCGGGCGAAGCCCTCGTCCACATCGCGTACAACTCCATCTGCGGCAGCGACCTCTCGCTCTACCGCGGTGTCTGGCACGGCTTCGGCTACCCCGTCGTGCCCGGACACGAGTGGAGCGGCACCGTGGTCGAGATCAACGGCGCCAACGGACACGACCAGTCGCTGGTCGGCAAGAACGTGGTGGGCGATCTGACCTGCGCGTGCGGGAACTGCGCGGCCTGCGGGCGCGGGACCCCGGTGCTCTGCGAGAACCTCCAGGAACTCGGCTTCACCAAGGACGGCGCCTGCGCCGAGTACATGACCATCCCGGTCGACAACCTCCGCCCGCTGCCGGACGCGCTGTCGCTGCGTAGCGCCTGCCAGGTCGAACCGCTCGCGGTGGCGCTCAACGCGGTCAGCATCGCGGGCGTCGCTCCCGGTGACCGGGTCGCCGTCATGGGGGCCGGGGGCATCGGCCTCATGCTGATGCAGGTCGCGAGGCATCTCGGCGGTGAGGTGACGGTCGTGTCCGAACCGGTCGCCGAACGGCGCGCGGTCGCCGGGCAGTTGGGCGCCACCGAGCTGTGCTCCGCCGAGCCGGGGCAGCTGGCCGAACTCGTCGCCCGGCGCCCCGAGCTCACGCCCGACGTGGTCCTGGAGGCATCCGGCTATCCGGCTGCGCTCCAGGAGGCCATCGAGGTGGTCAGGCCGGGCGGCCGCATCGGCCTGATCGGCTACCGGGTGGAGGAGACGGGACCGATGTCCCCGCAGCACATCGCGGTCAAGGCGCTGACCCTGCGCGGCTCGCTGGGCCCCGGCGGCCGCTTCGACGACGCCGTCGAACTGCTCGCGAAGGGCGACGACATCGCGGTCGAGCCGCTGCTCAGCCACGAGTTCGGCCTCGCCGACTACGCCACCGCGCTCGACCTGGCGCTGTCCCGCACGAACGGCAACGTGCGCTCCTTCTTCAACCTGCGCGACTAG	MKALVFHSPEKATFEQRDVPTPRPGEALVHIAYNSICGSDLSLYRGVWHGFGYPVVPGHEWSGTVVEINGANGHDQSLVGKNVVGDLTCACGNCAACGRGTPVLCENLQELGFTKDGACAEYMTIPVDNLRPLPDALSLRSACQVEPLAVALNAVSIAGVAPGDRVAVMGAGGIGLMLMQVARHLGGEVTVVSEPVAERRAVAGQLGATELCSAEPGQLAELVARRPELTPDVVLEASGYPAALQEAIEVVRPGGRIGLIGYRVEETGPMSPQHIAVKALTLRGSLGPGGRFDDAVELLAKGDDIAVEPLLSHEFGLADYATALDLALSRTNGNVRSFFNLRD	MVLVMKDIGITIYGSEQDEADVFQEISSRFGVTPTIVSSPISETNVMLAPKNKCISVGHKSEIHKSILIALKESGVKYISTRSIGYNHIDMKAAEKMGIAVENVTYSPDSVADYTLMLILMAIRHTKSTLCSMEKHDFRLNSVRGKVLRDLTVGVLGTGHIGKAVIERLQGFGGHVLAYGNNKEATANYVSFNELLQKSDILTIHVPLSDDTYHMIGHEQIKAMKQGAFLINTARGGLIDTEVLVKALEDGKLGGAALDVLEGEEGLFYFDCTQKPINNQFLLKLQRMPNVTITPHTAYYSEKTLRDTVEKTVKNCLEFERRETHE	105.21	gnl|BL_ORD_ID|1624|hsp_num:0	1724		
BGC0000702.1|Kanamycin_8 # 5722 # 6897 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.692	BGC0000702.1|Kanamycin_8 	5722	6897	+	Loose	800	39.6614	tetA(P)	21.31	3000180	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAGCTCGTTCCGCTCTTCCCGCTCTATCCCCTGCTCTTCTCCGACCACGGATTGTCGGGATCGGCGATCTCCTCGCTGCTCGTCCTGTGGTCGATGACCACGTTCGTCCTGGAGATCCCCTCGGGCGCGCTCGGCGACCTGCTGTCCCGCAGGCTGCTGCTCGCGTTCAGCGTGCTGCTGCGGGCGGGCGGGTTCAGCCTCTGGTTCATCGCACCCGGCTACTGGTCCTTCGCCGTCGGATTCCTGTGCTGGGGAGTCTGTGACGCCCTGACCTCCGGCACCCTGGAGTCCCTCGTCTACGACGAACTCCAGGACCGCGGCGAAGGACATGCCTACGGCCCCGTCATGGGCACCGGGCGGGCCATCTCGCTGCTCGCCACGCTCACCGCACTGCTCCTGGCCGGGCCGCTCTTCGTCCTCGGCGGGTACGGTCTGGTCGGCGCGGTCAGCGTCGGTGCGGGCGTGGCGGCCACCATCACCGCACTGACCTTCCCCAATCCACCGCGCCACGAGATCGAATCCGAACGCGGCGGCTTCCACCGCTATCTCGCCACCTTCAAAGCCGGGTTCGGGGAGGTCCGCAGGGAACGGGCCGTCATGCGGCTGGTGTTGATCGCCGCGATCCTGCAGAGCATGACGGCCATCGACGAGTACTTTCCGCTGCTCGCCCACGAGAACGGCGCGGCCAAGAGCCTCATCCCGGTCCTGGTGGCGATCCCCGTGCTGTGCGCCTCGGTGGGCAGCTGGATCGCGGGCCGCTCCACCGGCGTCTCGCGCAGGACCGCGTTCCTCACCGTGGCGGCGACCGGGCCGCTGCTGCTCCTCGGCGCCCAGAGCCACCACCAGTGGGGGATGCTCTCGATCGCCGTGGCCTTCGGCATCATCCAGTGGGGCATCGTGGTGTCCGGGCTCTGGCTCCAGGACGCCATCGTCGGATCGGCCCGCGCGACCATCACCTCCGTCGCGGGATTCGGCGCCGAGGTCTCCTCGGTCGGCTGGTACCTGGCCGCGGCCACCGCCCTCACGGTCACCGACGTCTCCGGCCTCACGTCGTGGTTCAGCCTCCCCTGCCTCCTGATCGCGGGCCTCACCTGGTTCTGGTTCCCGGAGCGACCGGCATCCGAGCCGACCGAACCGACCGAACCGCAGCCCACCACCTACTCGAAGAGGTAA	MELVPLFPLYPLLFSDHGLSGSAISSLLVLWSMTTFVLEIPSGALGDLLSRRLLLAFSVLLRAGGFSLWFIAPGYWSFAVGFLCWGVCDALTSGTLESLVYDELQDRGEGHAYGPVMGTGRAISLLATLTALLLAGPLFVLGGYGLVGAVSVGAGVAATITALTFPNPPRHEIESERGGFHRYLATFKAGFGEVRRERAVMRLVLIAAILQSMTAIDEYFPLLAHENGAAKSLIPVLVAIPVLCASVGSWIAGRSTGVSRRTAFLTVAATGPLLLLGAQSHHQWGMLSIAVAFGIIQWGIVVSGLWLQDAIVGSARATITSVAGFGAEVSSVGWYLAAATALTVTDVSGLTSWFSLPCLLIAGLTWFWFPERPASEPTEPTEPQPTTYSKR	MVNKLSAYKTYLLFSAITAMCFSLVATVMMVYHIEIVHLNPLQLILVGTTLELACFIFEIPTAIVADVYSRKLSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWIAEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLYMPENNFKPSAPGDLNTFKKMVYTFKSGLKFVKSKSIIMILLAVTLFYGLSSEGYDRLSNAHFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINILYISSMLIFALTRNFSLMLIAYLATNTFRIINKPIFSAWLNGHIDDNSRATVLSINGQMNSLGQILGGPIIGIIATNISVSIGIVCTSLLVTPVLVLYIVAMIIDKKVDDRVGGIDYEENN	93.10	gnl|BL_ORD_ID|477|hsp_num:0	508		
BGC0000702.1|Kanamycin_9 # 6903 # 8081 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.709	BGC0000702.1|Kanamycin_9 	6903	8081	+	Loose	400	24.6386	catB2	38.24	3002675	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	GTGTCCACGCACCCCGTCCTGGACTGGAGCCGATCCGCCGAACACCTGCGCCGCTCCCACGGCGTCACCACCGACCCCCGCCCCGACGAGGACGGCCACTACCCCTGCGTACTGACCCGGGGCAGCGGCACTCGCGTGTACGACCTGGACGGCAACGCCTACCTCGATCTCACCGGATCCTTCGGCTCGGTGCTCATCGGGCACGCGGAACCGGCCGTCGTACGGGCGGTGACCGACGTCCTGAGCGAAGGCAATCTCTTCTACACCGGCGCGAGCCCGCGCCGACTGGCCCTCGCGGAGCGGCTCCTTGACTGGTTCCCCTGGTCCGAGCAGGCCATCTTCTACCGCACGGGGTCCTGCGCGGTGTCCGCGGCGGCCCGGCTCGCCCAGCACGCGACCGGCCGCAACCGGGTGCTGAGTTCCGGCTACCACGGCTGGCACGACTGGCACCTGGAGGCGGTGCCCGAGGCCAAGCCCAAGACCTTCGAGTCGTACGCCACCGAGTTCCACAACGACCTGGCGCTCTACCGCTCCTGGCTCGACCGGCACGGCGAGGAGATCGCGGCGGTCGTGGTGACGCCCGAGCCGCACCGCTTCGACCACGCCTACTACCAGGAGCTGCGCGAGGTGGCCAAGGAGCACGGCTGCCTGTTCGTCGTGGACGAGGTCAAGACCGGCTTCCGGGCCGGGGCGGGCGGGTTCAGCGCCCTGGCCGGGATCGAGCCGGACGCCGTGACCGTCTCCAAGGGCATGGCCAACGGACACAGCATCTCCGCCGTGGTGGGCCAGCGACAGCTCACCCAGGAGCTGAGCGAGGCGCACGTCTGGTCCACCTACCAGAACGAACAGGTGGGGTTCGCCGCCGCGTTGGCGTCCCTGGACTTCCTGGAGCGGCACGACGTGGCGGCCGTGACGCGCCGCACGGGTGAGGCGGTCCGGCAGGGCGTGCTCCAGCTCTTCGCCGAACACGGCCTGCCCGTCGGGGCGCCGGGCTGGGGACCGATGTTCGAGCTGGACTTCGACGCCGCCGACGAGGGTCTCGCCGAGCGGCTCGAAGCGGCGCTGCTGCGCCACGGGATCTTCTGCGACACGGGCGACGACTTCAACATGATGTTCCATACCGCGGAGCACACCGACGAGCTCCTCGAGCGGTTCGCCGCCGCGCTCGGCGACCTCTGA	MSTHPVLDWSRSAEHLRRSHGVTTDPRPDEDGHYPCVLTRGSGTRVYDLDGNAYLDLTGSFGSVLIGHAEPAVVRAVTDVLSEGNLFYTGASPRRLALAERLLDWFPWSEQAIFYRTGSCAVSAAARLAQHATGRNRVLSSGYHGWHDWHLEAVPEAKPKTFESYATEFHNDLALYRSWLDRHGEEIAAVVVTPEPHRFDHAYYQELREVAKEHGCLFVVDEVKTGFRAGAGGFSALAGIEPDAVTVSKGMANGHSISAVVGQRQLTQELSEAHVWSTYQNEQVGFAAALASLDFLERHDVAAVTRRTGEAVRQGVLQLFAEHGLPVGAPGWGPMFELDFDAADEGLAERLEAALLRHGIFCDTGDDFNMMFHTAEHTDELLERFAAALGDL	MTNYFESPFKGKLLTEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDQLIIGSFCSIGSGAAFIMAGNQGHRYDWVSSFPFFYMNEEPAFAKSVDAFQRAGDTVIGSDVWIGSEAMIMPGIKIGHGAVIGSRALVTKDVEPYTIVGGNPAKSIRKRFSEEEISMLLDMAWWDWPLEQIKEAMPFLCSSGIASLYRRWQGTSA	186.67	gnl|BL_ORD_ID|670|hsp_num:0	712		
BGC0000702.1|Kanamycin_10 # 8089 # 9615 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.727	BGC0000702.1|Kanamycin_10 	8089	9615	+	Loose	450	27.7202	SLB-1	31.71	3003556	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	SHW beta-lactamase	GTGCGCATCATCTCCGTACAGGAGGCGGCCACCCGCACCTTCGACGTCTGCGTGGTGGGCAGCGGCGCCTCCGGTGCCATCACCGCCGCGGTGCTCGCCGAACGGGGCCTGTCCGTGCTCATCCTCGAACAGGGCACCGCGATCCCGCCGGGCACCGACCACGACGACGTCGAGGACCCCGACACCTGGGCGTACGCACGCGACGGGGAAGGCTGGAGCAAGGAGGGCTATCCCTGGAGCGCCATGGCGTTCGGCGGCGGCACGGTGTTCTACGGCGGCATCTCCTTCCGCTACGAACAGCGCGACCTCGACCCGCCGCCCGCGCTCCTCGGCGACGCCGACTACGCGCACTGGCGGCTGCGGCTCGACGAACTGGAGCCGCACTACGACTGGGTGGAGGACCGGCTCGGCGTGAGCGGCCCGTCCCACGGCCGGGTGGGCGACTACGCCTTCCCCCACTACGCGCGGGGCTCGCTGCCGCACACCCCGATGGGCGGCGCGCTGGCCCGGGGCGCCGACGCCCTGGGGCTGACCCCGCTGTCCACCCCGATGGCGATCAGCGGGGCCAGGGACCGGCACGGCCCCGGCTGCGCCGAGCTGACGCCGTGCACCGGCTTCACCTGCCCGGTCAACGCCAAGGCCGATGTGATCAGCCGCATCCTGGCGCGCGCCGAGGGGGACGTGTCCGTCGCCCTGGACACCAGAGCGGTGCGGTTCGTGGCCTCGGCACCGGGGCGGGCGAAACGTCTCGAAGTGCTCGGCGGCAGTCCCCGCAGCCGCCGCTCGGTCCATGCCGACCGCTTCGTCCTCGCGGCCAACGCCATCCAGTCCGCCGCGCTCCTGCTGCGTTCGGCGGACCGGCGCGAGCCGGACGGCATGGGGAACTCCAGCGGTCAGGTGGGCCGCCACCTGGCCATGAAGAACAGCGTCTACGTCCGCGGCAGGACCCAGGAGCGGATCGTCGCCCACCAGCCGCTGCGCCATCGCTACTCCAGCGTCTGCGTCCTGGACCACCTGCGCGGTGCGGAGTTCCCCGGGCAGCTGGGCGGGATCATCTACGAGGCCAACCCGTGGGAGGACCCCGAGGCCGACCGTCCTGGCGCCGGTTCGCTGCTCCAGCTGGAGTGCCTCCTCGGCGACCGCCCGCAGGCCCGCAACATGGTGCGGCTCGCCAGGAGCCGGGACCGGGACGGGCTCCAGCGCATCGTCATGGACTACCGCCAGCACCCCTTGGACGGCGAACGCCTGGACGTGCTCCAGGGGAAGGCGAAGGATGTACTGCACGCGGCCGGGGCCGAGCGCACCGAGTCCGTCGACAGCGATTTCGCGACCGGCAGCACGCATCTGCACGGCACGCTGCGCGCCGGTGACGACCCCGCGACCTCGGTGACCGACCGGACGGGCCGGCTGCACGACTACGACAACGTGTGGTCGGCGGACGGCGCGACGTTCCCCTTCGCCGGGAACTTCAATCCCACCCTCACCATCCAGGCCAATGCCCGGCGGATCGCGGTCGGCATCTCCTGA	MRIISVQEAATRTFDVCVVGSGASGAITAAVLAERGLSVLILEQGTAIPPGTDHDDVEDPDTWAYARDGEGWSKEGYPWSAMAFGGGTVFYGGISFRYEQRDLDPPPALLGDADYAHWRLRLDELEPHYDWVEDRLGVSGPSHGRVGDYAFPHYARGSLPHTPMGGALARGADALGLTPLSTPMAISGARDRHGPGCAELTPCTGFTCPVNAKADVISRILARAEGDVSVALDTRAVRFVASAPGRAKRLEVLGGSPRSRRSVHADRFVLAANAIQSAALLLRSADRREPDGMGNSSGQVGRHLAMKNSVYVRGRTQERIVAHQPLRHRYSSVCVLDHLRGAEFPGQLGGIIYEANPWEDPEADRPGAGSLLQLECLLGDRPQARNMVRLARSRDRDGLQRIVMDYRQHPLDGERLDVLQGKAKDVLHAAGAERTESVDSDFATGSTHLHGTLRAGDDPATSVTDRTGRLHDYDNVWSADGATFPFAGNFNPTLTIQANARRIAVGIS	MLSLPSYSHEVEPTSTTIQSVTSSLEGQLSISKLADGVYLHHSYKNVSNFGLVEANGLVVIKDKQAFIIDTPWTDNDTQKLVDWITQQGFIPVASISTHSHQDRAGGIGYLNRQGITTTVSETTQQILTENDKTTAKSTFTGMQYIMKTDLVEVYDLGAGHTKDNLVVWLPTQQILFGGCLIKSLNSSTLGYTGEADLQQWPLTIAKVQAQFPQVKIVVPGHGQVGDKALLEHTIELLIPKNETVNSSS	204.02	gnl|BL_ORD_ID|390|hsp_num:0	419		
BGC0000702.1|Kanamycin_12 # 11059 # 12231 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0000702.1|Kanamycin_12 	11059	12231	+	Loose	480	25.7942	adeR	35.0	3000553	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCAGGTCACCACCATCACGATGGATGACGTCCAGTATCCCTACCGATTAGGCACGGACTGCCTCGACGGCATCGTCACGCGCCTCGGCGAACTCGGCGCCAGCCGCTACCTGATCGTCAGCGACCCCAGGGTCGCCGAGCTGTACGGGCAGGGGCTGCGCGAACGGCTCGCGGAGCAGGCGGGACCCGCCGAGCTGATCACCCATGCCTCGGGAGAACAGAACAAGGGCCTGCCCGCACTGCACGACCTGGCCGAGGAGGCGCTGCGGCGCGGCGCCGACCGGCAGAGCATCGTCGTAGCACTCGGCGGCGGTGTCACCGGGAACATCGCGGGGCTGCTGGCCGCGCTGCTCTTCCGCGGCATCCGTCTGGTGCACGTGCCCACCACCGTGGTGGCCATGCTGGATTCGGTGCTCTCGCTCAAGCAGGCCGTGAACGCGGGAGTCGGCAAGAACCTGGTCGGCACCTTCTACCAGCCCGTCGAAGTGCTCGCCGACACCGCGATGCTGCGCACCCTGCCGGTCCGCGAGGTCAGGTCGGGGATGTGCGAGGTGGTGAAGAACTCGCTCGCCATCCGCCCCAGCATGATCGACCAGCTGTCGGCCGGGCTGCGCCCCGACGGCCGCTATCCCGACGACACGATGCACTGGATCATCTACGAGAGCCTGGCCGCCAAGGCCCAGGTCACGGCGTACGACAAGTACGAGCGCGGCGAGGGACTCATCCTGGAGTACGGGCACACCGTCGGGCACGCCGTGGAGCACTCCTCGCAGGGAGCCGTGCCGCACGGCGCCGCCGTCGCGCTCGGCATGATCGCCGCCGCCCAGGTCTCCCACCGGGCGGGCTGGGCCTCGGCCGAACTCGTCGACCTGCACCGGGAGCTCGTCGCCAAGACCGGGGTCGCGCGGCGCATCCCGTCCGACATACCGCTCTCCGCCGTCAGGCACCGCCTCTCCTTCGACAACAAGCGGGGCTACCTCCCGGCCTCCGCCGACACCTATCCGATGGTGCTGCTCGAATCCCCCGGCAAGGTGCTGCGCAGCGAGGGCACCGTCCTGACGGCGGCGCCACGGGACCTGGTCGACGCGGTGGTCGACGAACTCGCGGAACCCCCACGGCCCGCGGCCGCGAGGACCGACGACGCCGCCACCGTCCTCGGCGGTGCCGGGTGA	MQVTTITMDDVQYPYRLGTDCLDGIVTRLGELGASRYLIVSDPRVAELYGQGLRERLAEQAGPAELITHASGEQNKGLPALHDLAEEALRRGADRQSIVVALGGGVTGNIAGLLAALLFRGIRLVHVPTTVVAMLDSVLSLKQAVNAGVGKNLVGTFYQPVEVLADTAMLRTLPVREVRSGMCEVVKNSLAIRPSMIDQLSAGLRPDGRYPDDTMHWIIYESLAAKAQVTAYDKYERGEGLILEYGHTVGHAVEHSSQGAVPHGAAVALGMIAAAQVSHRAGWASAELVDLHRELVAKTGVARRIPSDIPLSAVRHRLSFDNKRGYLPASADTYPMVLLESPGKVLRSEGTVLTAAPRDLVDAVVDELAEPPRPAAARTDDAATVLGGAG	MFDHSFSFDCQDKVILVVEDDYDIGDIIENYLKREGMSVIRAMNGKQAIELHASQPIDLILLDIKLPELNGWEVLNKIRQKAQTPVIMLTALDQDIDKVMALRIGADDFVVKPFNPNEVVARVQAVLRRTQFANKATNKNKLYKNIEIDTDTHSVYIHSENKKILLNLTLTEYKIISFMIDQPHKVFTRGELMNHCMNDSDALERTVDSHVSKLRKKLEEQGIFQMLINVRGVGYRLDNPLAVKDDA	157.89	gnl|BL_ORD_ID|424|hsp_num:0	456		
BGC0000702.1|Kanamycin_13 # 12240 # 13349 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.738	BGC0000702.1|Kanamycin_13 	12240	13349	+	Loose	225	28.4906	Erm(41)	48.15	3000603	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGCGCGTCGGCGTCGTCGGTGCGGGGTTCATGGGCGGGGTGCACGCCGAGGTGGTGGCGGCTCATCCCGGCGCCCGGCTCGAAGCGGTGCACGACCTCGACCCCGCCGCCGCCAGGGACCTGGCCGAGCGGTTCCGCGCCGAGCGGGCCGAGCCCTCCTGGGCGGACCTGCTCGCCGACCCCGCGATCGACCTGCTCATCATCACCACGCCCAACGGGCTGCACCACCGGCAGGCGGCCGAGGCGCTGCGGGCGGGCAAGCACGTACTGGTGGAGAAGCCGCTCGGTGTCACGCCGGAGCAGGTGGCCGAGCTCGTCGAACTCGCCGGACGGCACGACCGGGTCCTTGCCCACGGAAGCAACTTCGTGCACAGCCCGAAGTTCGTCCGGGCCCGTCAACTGGTCGCGGACACCGAGGCGTTCGGACGGCCGCACCTGGTCCGGGTCGTCTTCCGCAACTCGGGCCCCGAGGCCGCCTGGGCCGCGTCCAAGGACCTCGCGGGCGGCGGAGCCCTCCTGGACCTGGGCTGTCACGCGGTGGAGCTGTGCCGGTGGCTGCTCGACGGCGCCGACGTCGAGTCGGTCAGCGCCCGACTGCAGCGGGTGCGGCCGCCCCACGACGCCGAAGCGGACCGCGCGTCCGGCACCGCGGGAACCGCGCGGGTCGCGCTGGAGGACCAGGCGCTGCTGGTCATGGAGTTCGCCGACGGCGCGGTCGGGCAGTGCGACGTCTCCTGGGTCACCCAGGGCGGTGAGCAGGTCACCGCGGAGATCATCGGCACCAAGGGCAGGGTCGAGGTCGACCTGTGGACCGGCATGGGGCTGCGCGCCTACTCGGACAAGGGCTATCAGGACGTCTGGGATCCCGAGCAGGGCTGGGTGCATCCGGAATGGGAGTGGATCCGGGCGAGCGGCTACTACCACCAGGACGGCACCGTGATCGAGGCGGTGGGCCAGGGCATCCCCCTCACCCACGGCCCCGCGGAAGCGCTCGCCTCGGCCCGTGTCCTGGCCACCGGTTACCGCAGTCACGCGGAGGGGCGGGTACTGCGGCTGTCCGGCGCGCCGGTCGGCCCTGGCGCGTCGACGACGGCGGCGGGCTCGGAATGA	MRVGVVGAGFMGGVHAEVVAAHPGARLEAVHDLDPAAARDLAERFRAERAEPSWADLLADPAIDLLIITTPNGLHHRQAAEALRAGKHVLVEKPLGVTPEQVAELVELAGRHDRVLAHGSNFVHSPKFVRARQLVADTEAFGRPHLVRVVFRNSGPEAAWAASKDLAGGGALLDLGCHAVELCRWLLDGADVESVSARLQRVRPPHDAEADRASGTAGTARVALEDQALLVMEFADGAVGQCDVSWVTQGGEQVTAEIIGTKGRVEVDLWTGMGLRAYSDKGYQDVWDPEQGWVHPEWEWIRASGYYHQDGTVIEAVGQGIPLTHGPAEALASARVLATGYRSHAEGRVLRLSGAPVGPGASTTAAGSE	MDLGAGHGALTAHLVAAGARVLAVELHPGRARHLRSRFAEEDVRVAEADLLAFRWPRRPFRVVASPPYQVTSALIRSLLTPESRLLAADLVLQRGAVHKHAKRAPVRHWTLRAGITLPRSAFHHPPQVDSSVLVIRRR	267.39	gnl|BL_ORD_ID|1899|hsp_num:0	2013		
BGC0000702.1|Kanamycin_14 # 13346 # 13501 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.763	BGC0000702.1|Kanamycin_14 	13346	13501	+	Loose	700	21.9422	cmx	50.0	3002703	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCGCCACCGAGCTCGGGGCGACCGCCGACACCGCCGGGCTCCGGAAGACCGCCGACGCCACCGGGCTCGGGATGACCGCCCGGGGCCGCGGCCGACCCGCCGCGGTGCCTCGTCCGTACCTCGTCCGCACCTCACCGATGGAGGGACCATGA	MTATELGATADTAGLRKTADATGLGMTARGRGRPAAVPRPYLVRTSPMEGP	MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVMAAFARRWPPRLTLIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANAGFLAVALSTATTLVPANQKGRALSILLSGTTIATVVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTNNVGRSETSATSPRLRVELSQLATPRLILAMALGALINGGTFAAFTFLAPIVTETAGLAEAWVSVALVMFGIGSFLGVTIAGRLSDQRPGLVLAVGGPLLLTGWIVLAVVASHPVALIVLVLVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIGAAAGPVLGALGLATGLGLLAPVWVASVLTAIALVIMLLTRRALTKTAAEAN	13.04	gnl|BL_ORD_ID|1283|hsp_num:0	1366		
BGC0000702.1|Kanamycin_15 # 13498 # 14754 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.700	BGC0000702.1|Kanamycin_15 	13498	14754	+	Loose	700	43.8986	LpsB	20.86	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGACCGAGCCTGCCAAGGGTGTGCTCGCGCTGACTCCGTTCTTTCTGTACTCGGAGTACCAGGACCACTGGGATCCCAAGTTCGACCCCATGGGCGGCATGCACCTGCTGGTGCGGGCCCTGGTCGAGGAGATGGCGGGCCGCGGCGTCCCGCACCGGGTCCTGACGATGTCACCGCCCAAGGTGCCCAAGGACATCAGGATCGGGCAGCGGATCAAGGTGCACGCCCGGCGGCTGCCCGTGCTGCCCATCCCCTCCGACCTGGAGGGGTACTTCGGACTCGTCGGCGCCTGGGCCAAGGGCAGCCTGTTGTGGGTGCTGCGCAACCGCAAGCGGCTGCGCCGGGAGATCGGCGCGGTGCACGCGCACTGCGACGGCTCGGGCGCCGCGGCCTTCTACCCGTATCTGATGTCCCGGATCCTCGGCGTGCCGCTGGTGGTCCAGATCCACTCCAGCCGCTATCTGAGCCAGCACCCCACCACGCTCTTCGAGCGGGTGACCGACCCGATCGCCAAGTGGGCGGAGCGGCACGCCGTCCGCAAGGCCGCCGCGGTCCTGATGCTCACCGACCGGGCCCGCGACGAGATGCGGCGCAAGGCCCAGCTGCCCGCGGAGCGCGTGCACCGGCTCGCGTACCTGGCCAGCGACCAGTTCAAGGACGCCGACACCGAGGCGAGGCGGGCGGAACTGCGGGAGCGCTACGGCCTCGACGACCGCCCGATCGTGCTCTACGTGGGGCGGATCGCCGCCGAGAAGGGCGTGGAGTACTACATCGAGGCCGCGGCCGAACTGACCCGCAGGGGCCGGGACTGCCAGTTCGTCATCGCCGGGGACGGTCCCGCCCGGCCGGACCTCGAAAAGCTGATCGGCGCCCGCGGGCTGCGCGACCGGGTGACCATCACGGGCTTCATGTCCCACGAGTTCATCCCATCCATGATCTCCCTGGGCGAACTCGTGGTGCTGCCGTCCCGGTACGAGGAGCTGGGCATCGTCATCCTGGAGTGCATGACCATGCGCAGGCCGCTGGTCGCGCACGACGTGAACGGCGTCAACAAGCTCATCGAGGACGGCACCACCGGAATCGTCGTACCCCCGTTCAGGACCCCGGAGATGGCCGACGCCGTCGAGCGGCTCCTCGACGATCCGGAGCTGCGCGAGCGGATGGCGGAGAACGCCGCCCCGCTGCCCGCCGCCAAGTACTCGCTCTCCGCGGCGGGCGACCAACTGGCGGGCATCTACCGGGAGATCGGGCTGTGA	MTEPAKGVLALTPFFLYSEYQDHWDPKFDPMGGMHLLVRALVEEMAGRGVPHRVLTMSPPKVPKDIRIGQRIKVHARRLPVLPIPSDLEGYFGLVGAWAKGSLLWVLRNRKRLRREIGAVHAHCDGSGAAAFYPYLMSRILGVPLVVQIHSSRYLSQHPTTLFERVTDPIAKWAERHAVRKAAAVLMLTDRARDEMRRKAQLPAERVHRLAYLASDQFKDADTEARRAELRERYGLDDRPIVLYVGRIAAEKGVEYYIEAAAELTRRGRDCQFVIAGDGPARPDLEKLIGARGLRDRVTITGFMSHEFIPSMISLGELVVLPSRYEELGIVILECMTMRRPLVAHDVNGVNKLIEDGTTGIVVPPFRTPEMADAVERLLDDPELRERMAENAAPLPAAKYSLSAAGDQLAGIYREIGL	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	114.21	gnl|BL_ORD_ID|2840|hsp_num:0	3793		
BGC0000702.1|Kanamycin_16 # 14751 # 15500 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.737	BGC0000702.1|Kanamycin_16 	14751	15500	+	Loose	500	26.1794	PNGM-1	34.67	3004571	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	PNGM beta-lactamase	GTGAGGGTCCTCCTCGTCTCCCCCCACCCCGACGACATCGCGCTGTCCTTCGGCGGCTGGGTCGCGGCCCACGCCCGCGGGCTCGCGGCCAAGGGCTGGCGGTTCGACCTGCTGACCGTCTTCGGCACGACCCTGTACGCGCCCCACAGCCCGCGCGCCGTCACCAAGGAGGCCATCAGCACGCTCCGGGAGCGCGAGGACCGCGACTACGCGCGCCGTCACGGGCTGCGGCTGACCTCTCTCCGGCAGGAGGACTGCTCCTGCCTGGGCATGGACGACGAGGAGGAGCTCATCGCCCCCGAGGCGACCGATCCTCGCCGGGCCGCCGTGCGGCAGCTGATCGCGGCGGCGCTCGCCGGGGCCGACCTGGTCGTCGCGCCGCTGGCTGTCGGCGGCCACGTGGATCACCGCATCGTCCGCACCGCGGTGCGGCAGTCGCTCGGCGCCACCCCCTGCCTCTGGTACGAGGACCTGCCGTACGCGTTGGAGAGCCCCGTCGAGGTGCCCTCCGACCACCGGCCCTGGCTGGTCGACATCAGGGGGCACGAGGCGGCCAAGCGCGCCGATCTCGCGCTGTACCGCTCGCAGATGACCGCCGCCGACACCTCCGAGGTCCTCTCGTACCGGCCGGACGGCGCGTCCGTCCCGTGCGAGCGGCTCTGGAGTTCGGCGGGCTTCCCCCAGGACCTGGCCGAGCGGATGGCACTGGCCACGCTGGCCGCCGTGACACCCGACAAGGAGTCGCTATGA	MRVLLVSPHPDDIALSFGGWVAAHARGLAAKGWRFDLLTVFGTTLYAPHSPRAVTKEAISTLREREDRDYARRHGLRLTSLRQEDCSCLGMDDEEELIAPEATDPRRAAVRQLIAAALAGADLVVAPLAVGGHVDHRIVRTAVRQSLGATPCLWYEDLPYALESPVEVPSDHRPWLVDIRGHEAAKRADLALYRSQMTAADTSEVLSYRPDGASVPCERLWSSAGFPQDLAERMALATLAAVTPDKESL	MAGGKVTSSTGIAPKRYVYYPGSEELGPDEIRVIACGTGMPTARRAQAAAAWVVELGNGDKFIVDIGSGSMANIQSLMIPANYLTKIFLTHLHTDHWGDLVSMWAGGWTAGRTDPLEVWGPSGSREDMGTKYAVEHMLKAYNWDYMTRAVTINPRPGDINVHEFDYRALNEVVYQENGVTFRSWPCIHAGDGPVSFALEWNGYKVVFGGDTAPNIWYPEYAKGADLAIHECWMTSDQMMTKYNQPAQLALRINLDFHTSAQSFGQIMNMVQPRHAVAYHFFNDDDTRYDIYTGVRENYAGPLSMATDMMVWNITRDAVTERMAVSPDHAWDVAGPSEDLAPDRNRASEYTQYILDGRLNVDEANAHWKQEFMGRTGLTTEDLGVGS	64.51	gnl|BL_ORD_ID|2771|hsp_num:0	3272		
BGC0000702.1|Kanamycin_17 # 15497 # 16756 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.692	BGC0000702.1|Kanamycin_17 	15497	16756	+	Loose	1900	26.1794	TriC	29.09	3003681	protein homolog model	n/a	n/a	triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCAAGAAGCTGGCGCTGTTCGGCGGAACTCCCGTACGGAACGAGGAGTTCTACGACGGCCCGCACATCGGGCCGCACGATCTCGACCGCCTCAAATCCGTCCTCGACTCGGGGAACTTCGGCGGCATCCCCTTCCCCAACACCCACCACACCGCCTTCGCCGACCTGTTCACCGGCAAGCTCGGCGCCCCGTACGGCCTGATGGTCTCCAACGGCACCATCAGTCTCTCCATCGCGCTGCGCGCCCTGGGCGTGCGTGCCGGGGACGAGGTGATCACCACCGGCTACACCTGGATGGGCACGGCCGCGGCGATCGTGCACATCAACGCCGTCCCCGTCCTGGTGGACATCGACCCCACGACCTGGTGCATCGACCCGGCGGCGGTGGAGGCGGCGATCACCCCGCGCACCAAGGTGATCGTCCCGGTCCATCTGGGCAATCAGATCGCCGACCTCGACGCGCTGCGGGCGATCGCCGACAAGCACGGACTCGCGATCCTGGAGGACACCGCGCACGGGCACTTCGCCGAGTGGCGGGGGCAGTGCGTGGGCACCCACGGGGACGCGGGCAGCTTCAGCTTCGAGAGCAGCAAGATCATGACTGCCGGTGAGGGCGGCTTCCTGGTGGCCAGGGACGAGGACGTGTACCAGCGGATGATGTCGCTGGCCAACTGCGGCCGCAAGGAGCCGGGTTACGACGGTTTCGCGGGCCGCACCCTGGGCTGGAACGCCCGCGCGAGCGAACTGCAGGCCGCCTTCATGATCGGGCAGGTCGAGCAGCACGACGCGCTGCACGCCAAGCGGGCGGCGAGCGCGGCGAAGCTCACCGCGGGGCTCGCCGAGATCGGCGGCTTCACTCCCGTGGGGAACGACGACCCGAGGATCACCCGGCGCCAGTACTACGAGGTCATCTACCGCTTCGACCCCGCCGCCTGGGAGGGGCTGCACCGGGACGAGGTCCTCTCGGCGATCCTTGCCGAGGGCATCGAGCTGGAGGGCGACGCCTTCTACCCGCCCGTACACAAGAGCGAACTGTTCGCGGTGGACGCCGTCCACTGGCCCATGATCGCCGAGAGGTACGGCGATCGGATCGGCCCGGACAGCGTCGACCTGCCCGTCGCCGACCGCGCCGCCGCCGACGAGTCCGTGTGGGTGCACCACGCGCTGCTCACCGGCGACGACAAGGACCTCGGCGACATCCTCGAAGCCGTCGCCAAGGTCCGCGACAACCTGCGAGAACTGCACGACGCGAGCTGA	MSKKLALFGGTPVRNEEFYDGPHIGPHDLDRLKSVLDSGNFGGIPFPNTHHTAFADLFTGKLGAPYGLMVSNGTISLSIALRALGVRAGDEVITTGYTWMGTAAAIVHINAVPVLVDIDPTTWCIDPAAVEAAITPRTKVIVPVHLGNQIADLDALRAIADKHGLAILEDTAHGHFAEWRGQCVGTHGDAGSFSFESSKIMTAGEGGFLVARDEDVYQRMMSLANCGRKEPGYDGFAGRTLGWNARASELQAAFMIGQVEQHDALHAKRAASAAKLTAGLAEIGGFTPVGNDDPRITRRQYYEVIYRFDPAAWEGLHRDEVLSAILAEGIELEGDAFYPPVHKSELFAVDAVHWPMIAERYGDRIGPDSVDLPVADRAAADESVWVHHALLTGDDKDLGDILEAVAKVRDNLRELHDAS	MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQMIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFRSEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEFGEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLRAGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELGDSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIVAVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFLMKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGAIRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPVGRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLGLSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIPLKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYRIEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAALLPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILLTAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR	41.28	gnl|BL_ORD_ID|2049|hsp_num:0	2194		
BGC0000702.1|Kanamycin_18 # 16915 # 17772 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=15bp;gc_cont=0.698	BGC0000702.1|Kanamycin_18 	16915	17772	+	Loose	750	26.1794	adeA	23.44	3000774	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCCTTGCCGCTCCGCCCGGCGAACTGACCCTCGCCCTCACACCGGACGACAAGACCCTCGATCCCGCCTCGCTCGACCGCGCGCTCGCCATACTCGCCGAGCACGGCATCCTGGTGCTGACCGGGATGCTCAGGACCCGGCTCACCGATCAGCTGCGCACGGCGATGCTCGACGACCTGCCCGAGGTGCTGCGGCAGCAGGACGTGCCCACGAACTTCGTGCCAGGACACGTCCAACAGGACCCGCCGGTACGGGAGTCGTTGCTCTTCCCCGACGTGCTGCTCAACCCGGTGGTCTACCAGATCACCCATGCCGTGCTCGGCGCGGACGCCCGCAACGCCGTCTACAGCGGCAACATGAACCTGCCGGGCAGCCACGAGCAGCCGGTCCACCTGGACGAGCCGCACCTGTGGCCGGGCATCAGCCACCCCCCGTACTGCCTCTGCGTCGACGTCCCCCTGATCGACTTCACGCTGGAGAACGGCAGCACCGAGTACTGGCCCGGCTCCCACGTCCTCAACCCCGACGAGTGCTACGACGAGCGGGGCTGTGTGCTGCCCGCCGAGCTGGAGCGGCGCCGGGCCGTCGCGCCGCCGGTCCGCTTCCCCATCCCCGTCGGCTCGGTCGTCATCCGCGACGGCAGGCTGTGGCACCGCGGCGTACCCAATCTGAGCGCGGCCCCCCGGCCCCTGCTGGCGATGACCCACTACACAGAGTGGTTCGACATGCCGCCGATCCAGCTGCCCGACACCGTCAAGTCCTGGGTCGACGGCTCCGATCGGCACACCCACGCGCACTTCGTGGCGGGCGACGTGGATCACCTGACGGGTGATCATCCCTTCGCCGTCCGCTGA	MALAAPPGELTLALTPDDKTLDPASLDRALAILAEHGILVLTGMLRTRLTDQLRTAMLDDLPEVLRQQDVPTNFVPGHVQQDPPVRESLLFPDVLLNPVVYQITHAVLGADARNAVYSGNMNLPGSHEQPVHLDEPHLWPGISHPPYCLCVDVPLIDFTLENGSTEYWPGSHVLNPDECYDERGCVLPAELERRRAVAPPVRFPIPVGSVVIRDGRLWHRGVPNLSAAPRPLLAMTHYTEWFDMPPIQLPDTVKSWVDGSDRHTHAHFVAGDVDHLTGDHPFAVR	MQKHLLLPLFLSIGLILQGCDSKEVAQAEPPPAKVSVLSIQPQSVNFSENLPARVHAFRTAEIRPQVGGIIEKVLFKQGSEVRAGQALYKINSETFEADVNSNRASLNKAEAEVARLKVQLERYEQLLPSNAISKQEVSNAQAQYRQALADVAQMKALLARQNLNLQYATVRAPISGRIGQSFVTEGALVGQGDTNTMATIQQIDKVYVDVKQSVSEYERLQAALQSGELSANSDKTVRITNSHGQPYNVTAKMLFEDINVDPETGDVTFRIEVNNTERKLLPGMYVRVNIDRASIPQALLVPAQAIQRNISGEPQVYVINAQGTAEIRPIEIGQQYEQFYIANKGLKVGDRVVVEGIERIKPNQKLALAAWKAPAVANHASSVETKTSIAEGAQP	71.97	gnl|BL_ORD_ID|1239|hsp_num:0	1313		
BGC0000702.1|Kanamycin_19 # 17747 # 18856 # 1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.735	BGC0000702.1|Kanamycin_19 	17747	18856	+	Loose	1200	28.4906	arnA	22.22	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGATCATCCCTTCGCCGTCCGCTGACGACGACGGCGGCCGACGGCGCGCCGTGAGCAGTCAACTCGCTCTGCGGGGGCCCGAGTTATCGGCCAATCTTTGCAAACCTGAGGAGGACACTTTGCGGGTTCTTGTCACCGGAGGCTCCGGCAACGTCGGTGTGGGTGTCGTCAGGGCACTCAACGCCGCCCGCCATCACGTCGTGGTGGCCAGCCGCGGCTACAGCCCCGCGCTCCTGCCCGAAGGCGTACGCGCCGTACGCCTGGAGCGCACCGAGCCCGACGCCTACACCAGGCTGGTCGCCGCCGAAAAGCCCGACGCCGTGATCGATCTGACCTGCCACGACGCCGCGGACGCGGCGGTCACCCTGCGGGCCTGCGCCGGGGTCGACCGCGTCGTGGTCGTCTCCTCGGTGACGGCCGCCGGGCCCGCCACCACCACTCCGGTCACCGAGGCGACAGCGGCACCGCCGCTCTCCGAGTACGGCATCGACAAGCTGGCCGTCGAGGAGACGGTGCGCGCCGCCTGGGCGGACGGCACCTCCCAGGCCCTGCTCGTGCGCCTGGGCGCGGTCTACCGGCTCGGCGCGGATCTGGACGGCCAACTCGCCGAGGACGGCTGCTGGCTGGCGCACGCGGCGGCCGGAGCGCCTGCCGTGCTCGCCGACGACGGCGCGGCGCGGTGGAACCTGCTGCACGCCGACGACGCGGGCGCCGCACTCGCCGAACTGCTGGCCAACGACCGCGCTCGCGGCGTCCTGGTCCACCTGGCCTCCCGGCATCCGCTGCCCTGGCGCGAGCTGTACGAGCGGGTCCACCACGCGCTCGGACGCCCCTTCAACCCGGTTTCCGTACCCGCGGAGTGGGCCGCCGAGCAGCTGGAGGACGCCGAGTTCCTCGCCGAGACCTCCCGCTGGGACCAGGTCTTCGACCTCGGCCTGCTCGACCGGCTCGCGCCGTCCTACCAGGAGCGCGGCGGACCGTCGCGCGTCACCGAGGTCGCCCTGTGGCTGATCCGCCAGGGGCGCGTCGGGGACGCGGAACTCGGCGCGGAGATACAGGAGTTGCCCGCGCGCCTCGCGGCCGTGCGCACCGCGCCAGGGCTGGTATGA	MIIPSPSADDDGGRRRAVSSQLALRGPELSANLCKPEEDTLRVLVTGGSGNVGVGVVRALNAARHHVVVASRGYSPALLPEGVRAVRLERTEPDAYTRLVAAEKPDAVIDLTCHDAADAAVTLRACAGVDRVVVVSSVTAAGPATTTPVTEATAAPPLSEYGIDKLAVEETVRAAWADGTSQALLVRLGAVYRLGADLDGQLAEDGCWLAHAAAGAPAVLADDGAARWNLLHADDAGAALAELLANDRARGVLVHLASRHPLPWRELYERVHHALGRPFNPVSVPAEWAAEQLEDAEFLAETSRWDQVFDLGLLDRLAPSYQERGGPSRVTEVALWLIRQGRVGDAELGAEIQELPARLAAVRTAPGLV	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	55.74	gnl|BL_ORD_ID|1549|hsp_num:0	1643		
BGC0000702.1|Kanamycin_20 # 18853 # 19815 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.679	BGC0000702.1|Kanamycin_20 	18853	19815	+	Loose	500	264.233	sgm	53.16	3000862	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGATTTCGGCCGATGTGATCGTTCCGCATGATCCCGGCTTCCGAAGATCAGTTACGTTCCTCGTCACGGGAGGGGCGGGCTCACCGTCCGCCCCGACCGGCGCGTTCACCCCATGGAGAGGATGGCCCATGTCGCAGTCCGCGTCCGACGAGGACCCCAAGTTAACGCGAGTCGTGGAGGCGGTCCGGGGCGGCAGGCGGTATCGGAGCGTGACCGACCAGGCCGTTCGCCGACTGGCCAGAGCGGCACTCGCTGTGGAGGGCGGCGACGTCACCAGGGCCACCAAGCGGACCAAGCGCGGACTCCACGAGGTCTTCGGCGCCTTCATGCCGATGACGCCCAAGTACGAGGCGCTGCTGCGCGATGTGCGGGAGGCCGTCGAGCTCGATGACCCGGAGGCGATCCGCACCGCCCTGAAACCCGCCCTCGGCGCCCACTCCTCCACCAGGGAGCGGCTCCCCATCCTCACGGAAATGTACGCCGAGGTCTTCGACCGCCTCGACACCGCCCCCGCCACCGTGCGCGACCTGGCCTGCGGGATGAACCCGCTGACCGTCCCCTGGATGCCGCTGCCCGCCGGGACGACCTACCTCGCCTCCGACATCGACCACCGTCTGATGGACTTCGCGGGAACGGTGCTCACCGCTCTCGGAGTCCCCAACCGGGTAGAGGTGCGGGACCTGTTGACGGACCCGGATCCCGAACCGGCCGACGTCACCTTCCTGTTCAAGGCCGTCCCCTGCCTTGAGGCACAGGGCAAGGGCCTCGGCTGGAAGCTGCTCGACCAGATCAATTCCCCCGTCCTGGTGGTGAGTTTCCCCACCAAGACCCTGGGCCGCCGCTCCAGGGGCATGTACCAGACCCATTCCGCGGAATTCGCCCGGCGCGTCGCCGAACGGCCCTGGAAGTGCGACGAGATCGAGTTCGGCGACGAACTCGTCTACGTGGTCACGAAGGGCTGA	MISADVIVPHDPGFRRSVTFLVTGGAGSPSAPTGAFTPWRGWPMSQSASDEDPKLTRVVEAVRGGRRYRSVTDQAVRRLARAALAVEGGDVTRATKRTKRGLHEVFGAFMPMTPKYEALLRDVREAVELDDPEAIRTALKPALGAHSSTRERLPILTEMYAEVFDRLDTAPATVRDLACGMNPLTVPWMPLPAGTTYLASDIDHRLMDFAGTVLTALGVPNRVEVRDLLTDPDPEPADVTFLFKAVPCLEAQGKGLGWKLLDQINSPVLVVSFPTKTLGRRSRGMYQTHSAEFARRVAERPWKCDEIEFGDELVYVVTKG	MTAPAADDRIDEIERAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEIYGAFLPPSPPNYAALLRHLDSAVDAGDDEAVRAALLRAMSVHISTRERLPHLDEFYRELFRHLPRPNTLRDLACGLNPLAAPWMGLPAETVYIASDIDARLVGFVDEALTRLNVPHRTNVADLLEDRLDEPADVTLLLKTLPCLETQQRGSGWEVIDIVNSPNIVVTFPTKSLGQRSKGMFQNYSQSFESQARERSCRIQRLEIGNELIYVIQK	116.79	gnl|BL_ORD_ID|1952|hsp_num:0	2079		
BGC0000702.1|Kanamycin_21 # 19898 # 21142 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.721	BGC0000702.1|Kanamycin_21 	19898	21142	+	Loose	700	47.3654	LpsB	24.66	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	GTGCGCGTACTCCGGCTCACCCCGTTCTACCACCACGACTGTGTGGACAGCTGGCCCGCCGAGTTCGACGCGGTGGGCGGCATGCAGGTACAGATCCTGCGGATGTCCCGCGCCCTGGCCGAGTTGGGGGTGCGCCAGCAGGTGCTCACCGTCGGCTTCCCCGGTCTGCCCAGAGTGCGGCGCGACTCCGAGAACCTGGTGGTGCGGATCACCAGGGCCCCGCTGCCCAGGCTGCGCTCCAGGATCACCGGCCTGGTCGGCCTCAACCAGGCGTGGCTGGCCGCCGCGCTCACCGAATGCGTGAAACTGCGGCGCCGCTGGCCCGCCGACCTGATCCAGGTCCATCTGGACGGCCAGCTCTGGGCGTTGCTCGCGGGACCGGTCGCCGCCCGCCTGGTGGGCGTGCCGTACACGGTCACCGTGCACTGCTCGCGGCTGGCGGTGTATCAGCCCATGTCCACCGTCGACCGCATCCAGCACCCCTTGGTGACCGCCGTCGAGCGCTGGGCGCTGCGCCGTGCGGCCGGGATCACCACGCTGACCGAGCGGACCGCCACGGTGCTCGCCGCCGAACTGGGCGCGGCCCAGAGGGTGATCGACGTGGTGCCCGACGCGGTCGACCCCGATCGGGCCGAGGCCGCGCCCGCCGAGGTCGAGCGGCTGAAGAAGCGTTTCGGCCTGCCGCAGGAGGGCGGTCCCGTCATCGGATTCGTCGGCCGGATCGCCCACGAGAAGGGCTGGCGCCACGCCGTCCAGGCGGTGGCCGAACTCGCGGACGCGGGCCGGGACTTCACCTTCCTCGTCGTCGGAGACGGACCGCAGCGGGCCGACATGGAGGCGGCGGTGGCCGAGGCCGGTCTCACCGACCGGTTCGTCTTCACCGGGTTCCTGCCCAACGACGAGATCCCCGCCGTGATGACCGCCCTGGACGTCCTCCTGATGCCGTCCGTGCACGAGGAGTTGGGCGGCAGCGCCGTCGAGGCCATGCTCGCGGGAACGCCGGTGGCCGCCTACGGGGTCGGCGGCCTGTGCGACACCGTGGGCAAGGTGACCCCGTCCTTGCTGGCCGCGCCCGGCCAGGTGGCCGAACTCGCGCGGACGGTCAAGCGGGTACTCGACGATCCCGCGCCGGTCCTGGCCGAATTGCGTGCCGGACGGGAGTGGCTCGCGGACGAGTTCGGTGTCCACCACGCGGCCGGTCTCGCGTTGGCCCACTATGAGCGGGTACTCGGCAAAGAACGGTAG	MRVLRLTPFYHHDCVDSWPAEFDAVGGMQVQILRMSRALAELGVRQQVLTVGFPGLPRVRRDSENLVVRITRAPLPRLRSRITGLVGLNQAWLAAALTECVKLRRRWPADLIQVHLDGQLWALLAGPVAARLVGVPYTVTVHCSRLAVYQPMSTVDRIQHPLVTAVERWALRRAAGITTLTERTATVLAAELGAAQRVIDVVPDAVDPDRAEAAPAEVERLKKRFGLPQEGGPVIGFVGRIAHEKGWRHAVQAVAELADAGRDFTFLVVGDGPQRADMEAAVAEAGLTDRFVFTGFLPNDEIPAVMTALDVLLMPSVHEELGGSAVEAMLAGTPVAAYGVGGLCDTVGKVTPSLLAAPGQVAELARTVKRVLDDPAPVLAELRAGREWLADEFGVHHAAGLALAHYERVLGKER	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	113.11	gnl|BL_ORD_ID|2840|hsp_num:0	3793		
BGC0000702.1|Kanamycin_22 # 21315 # 22208 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.734	BGC0000702.1|Kanamycin_22 	21315	22208	+	Loose	1150	31.9574	tetB(46)	41.86	3004033	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGTGGTCGGGGTCGATCGCGGCCGGTGGACCTGCGTCCTGGACTCCGACCCCGAGAGCCGGATCACCGCGATGCGCGCCCGCGAACTGGGCCGCAAGTCGGCGGTGATAGGCGACCGCGTCGACGTGATCGGCGACCTGTCCGGCAAGCCGGGCACCCTGGCCCGCATGGTCCGGGTCGCCCGGCGCGACAGCGTCCTGCGGCGCACCGCCGACGACACGGACCCCTACGAGCGGGTGGTGGTCGCCAACGCGGAACAGCTGGTGATCGTCTGCGCGTTGGCGGCGCCGCAGCCGCGCGCCGGTTTCATCGACCGTGCCCTGGTGGCGGCCTACGCGGGCGGTCTGCGGCCGGTGCTCTGCCTGACCAAGGCGGACCTGAAGGGCCCCGAGGACGTGGTGAGCACCTACGCCCATCTGGATCTGTCGATCGTGGTCACGCGCTCCGACCGCGCCCCGGACGCCCTGCGCGAGCAGCTGGCCGGGCGCGTCTCGGCCCTGGTCGGACACTCCGGAGTCGGCAAGTCCACGCTGATCAACATCCTGATCCCGCAGGCCCGGCGGGTCACCGGTGAAGTGAGCGCGATCGGGAAGGGCCGCCACACGTCCACCTCGGCCGTCGCCCTGCCGCTGCCGGACGGCGGCTGGGCCGTGGACACCCCCGGCATCCGCTCCTTCGGGCTTGCCCACGTCACGTCCGACGACGTCCTCGACGCCTTCCCCGACCTGAGCGACGGCGCGGAGGACTGCCCGTCCGGCTGCCGTCATCTGGGCGCCCCGCACGACTCGGGATGCGGCCTGGAGCGCCTGAGCGAAGCCGATCCGGCCAGGGCGCGGCGGCTGGAGTCGCTGCGCCGCCTGCTGCGCTCGCACGCGGGCATCGAAGAGGAGTGA	MVVGVDRGRWTCVLDSDPESRITAMRARELGRKSAVIGDRVDVIGDLSGKPGTLARMVRVARRDSVLRRTADDTDPYERVVVANAEQLVIVCALAAPQPRAGFIDRALVAAYAGGLRPVLCLTKADLKGPEDVVSTYAHLDLSIVVTRSDRAPDALREQLAGRVSALVGHSGVGKSTLINILIPQARRVTGEVSAIGKGRHTSTSAVALPLPDGGWAVDTPGIRSFGLAHVTSDDVLDAFPDLSDGAEDCPSGCRHLGAPHDSGCGLERLSEADPARARRLESLRRLLRSHAGIEEE	MKVLKRLLSRITLYPTVFLAGFICLLLATIFSELSPFLLQKMIDGPLTALTHGGGQGDLLQMGGFYLLVLSLGQLISYMGNRILLHGSNQVTASLRDQAFQVMQGLPISYFDDKPAGKIATRIVNDTETLRTQFYNSCMILVIYLVRFLFILGILFYLSPMMGLLLCLVFPIFYGIQYLYKVMTDQPMKDFFDARSEVNTQVNELLHGASMIQLYHQEPGVVEEFEATTQKMLGANDRILLADSIASWTLTELLKFLVIAGILTIAGISFLQGNIGVTAGFLFININYVINLFDLMANLSRQFPNIRRSLETGSRVLAFLDQPLEADGALELKIEKAEVVFDDVQFAYEEGKPVLKDISIQAHPGQTLALVGHTGSGKSSIMNLLYRFYDPQEGEIRIDGQNIRHFSRESLRSHMGIVLQDPYLFTGTIASNVAMSQEHIDRNAVKDALKKVGAWPFVERLEKGIDHPVVEKGSAFSSGERQLISFARTLYMNPQILILDEATSHIDTETEEIIQKAMAVLQKGRTTFIIAHRLSTIQDADQILVLSEGRIVERGQHADLVAHGGIYAQMQAIQQTVE	51.38	gnl|BL_ORD_ID|2371|hsp_num:0	2644		
BGC0000702.1|Kanamycin_23 # 22225 # 22641 # 1 # ID=1_23;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.710	BGC0000702.1|Kanamycin_23 	22225	22641	+	Loose	500	25.409	SPG-1	50.0	3003720	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPG beta-lactamase	GTGGTCCACCATGGGGACATGAGCCGACTGACCCACATCAGCGCCCCCGAGGGCGTCGCCCCCGCCACCGCCTACACCCACGTCGTGATGGGCACGGGCCGATTCGTCGCGATATCCGGCCAGTTGGCCCTGGACGAGGACGGCAAGCTGGTCGGCGAGGGCGACGCGGCGGCGCAGGCCCACCAGGTCTTCGAGAACCTGCGGCGCTGCCTGACCGCGGCGGGCGCGACGTTCGACGACGTCGTGAAGCTGACGTACTTCGTGACGGACATGGCGCACATGCGGGCGATCCGCGGCGCGCGGGACGCCTTCCTTGACCCCGAGCGGCTGCCCGCTTCCTCGGCGGTGCAGGTGGGCGCGCTGGTCGCGCCCGAGTATCTGATGGAGATCGAGGCGTTCGCGGTGGTGGCCGAGTAG	MVHHGDMSRLTHISAPEGVAPATAYTHVVMGTGRFVAISGQLALDEDGKLVGEGDAAAQAHQVFENLRRCLTAAGATFDDVVKLTYFVTDMAHMRAIRGARDAFLDPERLPASSAVQVGALVAPEYLMEIEAFAVVAE	MRPLILLASALAMTAPSGALAQSAEQRAKWNGPREPFRITGNLYYVGTSGLSAYLIAGPRGHVLIDGALPESAPLIAANIRKLGFKLSDVKYLLSNHSHVDHAGGLAELKRLTGAQMVANVADKPDLEAGTTIGRTDIADFPAVKVDRVIGDGDRLTLGPIALVAILTPGHTKGATSWTTRIGSKNVIFTSSISVAGQNLINNINYPNAAADFRASFAKLRALKADIFLSFHAEAFALDEKRARAQAGATDAFVDPNELSRQVDLAEKAFDATLAKQQAANADRR	48.42	gnl|BL_ORD_ID|2078|hsp_num:0	2235		
BGC0000702.1|Kanamycin_24 # 22665 # 23336 # -1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=14bp;gc_cont=0.747	BGC0000702.1|Kanamycin_24 	22665	23336	-	Loose	500	25.7942	chrB	48.48	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGCCCCGCTCACATGAGATTAACCGGCGAGTAACGAGCGCGCCAGCCCTCAGTGTTTGTGATCTACGTCGCCGGGAGGGATCGGCGGTTAGGCTCGCGGCCATGGATGAGGAGTTGCGGACGGTGACGGAACGTTTACGCGCCGAGGCGGGGGGCTCGAAGGAGTACGAGCGGCTGGTCGCGACCGGTGACCTCGAGGAGCTCGCCGAGGTGCTCGTCTCGCCGGGACAGCCCTTGTGGACAAGGGAGTTGGCGGCGGTCCTGCTCGGCGTCGCCGGGGACCGCCGGGCCTTCGAATCGCTCGTCCTGCTCCTCAACCACCGGGACGCGCCGCGCTGCGCGGCGGCGGCGTACGCCCTGGCCAGGCTCGGCGACCCCCGCACCGCGCGCGCGGCGGCCGCCCTGGCGACGAACGAACTCCGCGTCGCCTACGCCCTGCACCCGGTGCGCCTCCTGACGGAGCTGCGCGCCCCGGAGTCGGCGCCCGCGCTGATCACGACGCTGCGGCGGCGCCTCGCCCCGCACGACCCGTTCGGCAAGATCGCGCTCGCCTGTGTGGAGGGCCTGGGCGCGCTCGGGGACCCCCGGGCGAGACCGGTGCTGACCGCGGCGCGGGCCCATCCCCGCCTCGCGGCGGCGGCCTCGGCGGCCCTGGCGCGGCTGCCGGAGTGA	MPRSHEINRRVTSAPALSVCDLRRREGSAVRLAAMDEELRTVTERLRAEAGGSKEYERLVATGDLEELAEVLVSPGQPLWTRELAAVLLGVAGDRRAFESLVLLLNHRDAPRCAAAAYALARLGDPRTARAAAALATNELRVAYALHPVRLLTELRAPESAPALITTLRRRLAPHDPFGKIALACVEGLGALGDPRARPVLTAARAHPRLAAAASAALARLPE	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	79.64	gnl|BL_ORD_ID|284|hsp_num:0	305		
